Viking Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $134M | 2.1M | 63.31 |
| 2024-06-30 | $119M | 2.3M | 53.01 |
| 2024-03-31 | $85M | 1.0M | 82.00 |
| 2023-12-31 | $11M | 568k | 18.61 |
| 2023-09-30 | $6.2M | 557k | 11.07 |
| 2023-06-30 | $8.9M | 547k | 16.21 |
| 2023-03-31 | $44k | 2.6k | 16.76 |
| 2022-12-31 | $4.0k | 498 | 8.00 |
| 2022-06-30 | $184k | 46k | 4.00 |
| 2022-03-31 | $98k | 33k | 2.99 |
| 2021-12-31 | $0 | 27k | 0.00 |
| 2021-03-31 | $250k | 39k | 6.35 |
| 2020-12-31 | $172k | 30k | 5.77 |
| 2020-09-30 | $145k | 24k | 5.93 |
| 2020-06-30 | $159k | 22k | 7.21 |
| 2020-03-31 | $133k | 22k | 6.21 |
| 2019-12-31 | $133k | 21k | 6.21 |
| 2019-09-30 | $133k | 21k | 6.21 |
| 2019-06-30 | $149k | 18k | 8.36 |
| 2019-03-31 | $148k | 15k | 9.97 |
| 2018-12-31 | $117k | 15k | 7.64 |
| 2018-09-30 | $209k | 12k | 17.40 |
| 2018-06-30 | $84k | 8.8k | 9.50 |